ASML Holding N.V. (LON:0QB8)

Market Cap	200.87B
Revenue (ttm)	27.48B
Net Income (ttm)	8.04B
Shares Out	n/a
EPS (ttm)	20.52
PE Ratio	24.97
Forward PE	26.12
Dividend	5.49 (0.92%)
Ex-Dividend Date	Jul 28, 2025

Volume	46,399
Average Volume	233,630
Open	606.90
Previous Close	613.10
Day's Range	590.60 - 612.50
52-Week Range	508.30 - 899.90
Beta	1.22
RSI	36.97
Earnings Date	Jul 18, 2025

About Theseus Pharmaceuticals

ASML Holding N.V. provides lithography solutions for the development, production, marketing, sales, upgrading, and servicing of advanced semiconductor equipment systems. It offers lithography, metrology, and inspection systems. The company also provides extreme ultraviolet lithography systems; and deep ultraviolet lithography systems comprising immersion and dry lithography systems solutions to manufacture various range of semiconductor nodes and technologies. In addition, it offers metrology and inspection systems, including YieldStar optical ...

• Industry: Special Industry Machinery, not elsewhere classified
• Founded: 1984
• Employees: 42,786
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0QB8

Financial Performance

In 2024, ASML Holding's revenue was 28.26 billion, an increase of 2.56% compared to the previous year's 27.56 billion. Earnings were 7.57 billion, a decrease of -3.41%.